Henry Schein
Henry Schein, Inc., a leading global provider of healthcare products and services, is headquartered in the United States. Founded in 1932, the company has established a strong presence in the dental, medical, and veterinary sectors, serving healthcare professionals across North America, Europe, and Asia. With a diverse portfolio that includes dental supplies, medical equipment, and practice management software, Henry Schein is renowned for its commitment to innovation and customer service. The company has achieved significant milestones, including its recognition as one of the Fortune 500 and its consistent ranking among the top healthcare distributors globally. Henry Schein's unique approach combines comprehensive product offerings with tailored solutions, making it a trusted partner for healthcare providers seeking to enhance patient care and operational efficiency.
DitchCarbon Score
How does Henry Schein's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Henry Schein's score of 69 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Henry Schein's reported carbon emissions
In 2023, Henry Schein reported total carbon emissions of approximately 834,000,000 kg CO2e, with significant contributions from Scope 1, Scope 2, and Scope 3 emissions. Specifically, Scope 1 emissions were about 58,304,000 kg CO2e, while Scope 2 emissions totalled approximately 24,177,000 kg CO2e. The most substantial impact came from Scope 3 emissions, which reached approximately 776,259,000 kg CO2e, highlighting the importance of addressing upstream and downstream activities in their carbon footprint. Henry Schein has set ambitious climate commitments, aiming to reduce its Scope 1 emissions by 42% by 2030, using 2022 as the baseline year. Furthermore, the company has pledged to achieve a remarkable 90% reduction in Scope 1 emissions by 2050. In addition to these targets, Henry Schein is committed to sourcing 100% renewable electricity by 2030 and has set a goal to reduce Scope 3 emissions by 51.6% per million USD value added by 2030, with a long-term target of a 97% reduction by 2050. The company has submitted its near- and long-term targets to the Science-Based Targets initiative, committing to reach net-zero greenhouse gas emissions across its value chain by 2050. These initiatives reflect Henry Schein's dedication to sustainability and its proactive approach to mitigating climate change impacts within the healthcare sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | - | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 48,846,000 | 00,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Henry Schein is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
